UCSF

ZINC00033882

Substance Information

In ZINC since Heavy atoms Benign functionality
October 3rd, 2005 11 No

Other Names:

"Dopamine hydrochloride, 99%"

(3H)-Dopamine

(Dopamine HCl)

pamine

.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane

.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride

1,2-Benzenediol, 4-(2-aminoethyl)-

1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)

1,2-Benzenediol, 4-(2-aminoethyl)- (9CI); 1,2-benzenediol, 4-(2-aminoethyl)-; 2-(3,4-Dihydroxyphenyl)ethylamine; 2-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; 3,4-Dihydroxyphenethylamine; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylet

1,2-Benzenediol, 4-(2-aminoethyl)-, hydrobromide; 3,4-Dihydroxy-phenethylamine hydrobromide; 4-(2-Aminoethyl)-1,2-benzenediol hydrobromide; 4-(2-Aminoethyl)pyrocatechol hydrobromide; Dopamine hydrobromide; EINECS 211-436-8; LS-103276; NSC 44457; Phenethyl

1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride

1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride (1:1)

1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 3,4-Dihydroxyphenethylamine hydrochloride; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)benzene-1,2-diol hydrochloride; ASL 279; C8H11NO2.HCl; DOPAMINE HCL

1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium

153C5321-5FEE-4B0B-8925-F388F0EEEBD1

2- ETHYL-1,1,2,2-D4-AMINEHCL

2-(3,4-dihydroxyphenyl)ethan-1-aminium; dopamine; dopaminium cation

2-(3,4-Dihydroxyphenyl)ethyl-1,1,2,2-D4-amine hydrochloride

2-(3,4-dihydroxyphenyl)ethylamine

2-(3,4-Dihydroxyphenyl)ethylamine hydrochloride

2-(3,4-Dihydroxyphenyl)ethylamine; 3,4-Dihydroxyphenethylamine; 3,4-Dihydroxyphenylethylamine; 3-Hydroxytyramine; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-aminoethyl)-Pyrocatechol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; a-(3,4-Dihydroxyphen

2-(3,4-Dihydroxyphenyl)ethylamine; 3,4-Dihydroxyphenethylamine; 3,4-Dihydroxyphenylethylamine; 3-Hydroxytyramine; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-Pyrocatechol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; Deoxyepinephrine; Do

2-(3,4-dihydroxyphenyl)ethylamine; 3,4-dihydroxyphenethylamine; 3-hydroxytyramine; 4-(2-aminoethyl)benzene-1,2-diol; 51-61-6; deoxyepinephrine; dopamine; hydroxytyramine; intropin

2-(3,4-Dihydroxyphenyl)ethylamine; 3,4-Dihydroxyphenethylamine; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 51-61-6; C03758; Dopamine

2-(3,4-Dihydroxyphenyl)ethylamine;3,4-Dihydroxyphenethylamine;3,4-Dihydroxyphenylethylamine;3-Hydroxytyramine;4-(2-Aminoethyl)-1,2-benzenediol;4-(2-Aminoethyl)-Pyrocatechol;4-(2-Aminoethyl)catechol;4-(2-Aminoethyl)pyrocatechol;a-(3,4-Dihydroxyphenyl)-b-am

2-(3,4-Dihydroxyphenyl)ethylamine;3,4-Dihydroxyphenethylamine;3,4-Dihydroxyphenylethylamine;3-Hydroxytyramine;4-(2-Aminoethyl)-1,2-benzenediol;4-(2-Aminoethyl)-Pyrocatechol;4-(2-Aminoethyl)catechol;4-(2-Aminoethyl)pyrocatechol;Deoxyepinephrine;Dopamin;Dop

2-benzenediol

3,4-dihydroxyphenethylamine

3,4-Dihydroxyphenethylamine hydrochloride

3,4-Dihydroxyphenylethylamine

3-Hydroxtyramine

3-Hydroxytyramine

3-Hydroxytyramine Hydrobromide

3-Hydroxytyramine hydrobromide

3-Hydroxytyramine hydrochloride

3-Hydroxytyramine hydrochloride, 99%

3-HYDROXYTYRAMINE HYDROCHLORIDE; CPD000059081; Dopamine hydrochloride; Intropin; SAM002554938

3-Hydroxytyramine, HCl

3-Hydroxytyramine; 4-(2-aminoethyl)catechol; 4-(2-aminoethyl)pyrocatechol; Deoxyepinephrine; Hydroxytyramin

3-Hydroxytyraminehydrobromide

3-Hydroxytyraminehydrochloride

4-(2-Aminoethyl)-1,

4-(2-Aminoethyl)-1,2-benzenediol

4-(2-Aminoethyl)-1,2-bezenediol

4-(2-aminoethyl)-pyrocatechol

4-(2-aminoethyl)benzene-1,2-diol

4-(2-aminoethyl)benzene-1,2-diol hydrobromide

4-(2-Aminoethyl)benzene-1,2-diol hydrochloride

4-(2-Aminoethyl)catechol

4-(2-Aminoethyl)pyrocatechol

4-(2-Aminoethyl)pyrocatechol hydrochloride

50444-17-2

51-61-6

51-61-6; D07870; Dopamine (INN); Medopa (TN)

62-31-7 (HYDROCHLORIDE)

62-31-7; Actopamin (TN); D00633; Dopamine hydrochloride (JP16/USP); Intropin (TN)

a-(3,4-Dihydroxyphenyl)-b-aminoethane

AC1L19S5

AC1Q54AX

AC1Q54AY

AKOS003790978

alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane

ASL 279

ASL 279, Cardiosteril, Dopamine Fresenius, Dopastat, Intropin, Rascordin, Revivan, Tensamin

ASL-279

BIDD:ER0506

Biomol-NT_000001

BPBio1_001123

BSPBio_001932

C03758

CHEBI:11695; CHEBI:43686; CHEBI:14203; CHEBI:11930; CHEBI:23886; CHEBI:1764

CHEBI:18243

CHEMBL59

CID681

cMAP_000036

cMAP_000065

CPD000059081; Intropin; SAM002554938

D07870

DA

DAP000212

DB00988

Deoxyepinephrine

DivK1c_000780

Dopamin

Dopamin-Natterman

Dopamina

Dopamina [INN-Spanish]

dopamina; dopamine; dopaminum

Dopamine

Dopamine (BAN

Dopamine (INN)

Dopamine (USAN)(*hydrochloride*)

Dopamine HCl

Dopamine Hydrochloride (FDA

Dopamine hydrochloride (Inotropin)

Dopamine hydrochloride, 99%

Dopamine [INN:BAN]

Dopamine-d4 HCl

Dopamine-d4 hydrochloride

dopaminium(1+)

Dopaminum

Dopaminum [INN-Latin]

Dophamine

Dynatra

EINECS 200-110-0

FDA)

HSDB 3068

Hydroxytyramin

Hydroxytyramine

IDI1_000780

INN)

INN); Dopamine HCl (FDA

INN); Dopamine HCl (JAN

Intropin

Intropin [*hydrochloride*]

IP 498

JAN

KBio1_000780

KBio2_001492

KBio2_002388

KBio2_002484

KBio2_004060

KBio2_004956

KBio2_005052

KBio2_006628

KBio2_007524

KBio2_007620

KBio3_001152

KBio3_002867

KBio3_002962

KBioGR_001129

KBioGR_002388

KBioGR_002484

KBioSS_001492

KBioSS_002393

KBioSS_002491

KW-3-060

L-DOPAMINE

L000232

LDP

LS-159

m-Hydroxytyramine hydrochloride

m-Hydroxytyramine-

Medopa (TN)

MFCD00012897

MFCD00012898

MFCD00130258

MolPort-001-641-000

NA

NCGC00015519-01

NCGC00015519-08

NCGC00096050-01

NCGC00096050-02

NCGC00096050-03

NCGC00096050-04

NCGC00096050-05

nchembio.105-comp9

nchembio.107-comp4

nchembio.284-comp1

nchembio.78-comp16

nchembio.89-comp3

nchembio705-8

nchembio801-comp8

NINDS_000780

NSC 173182

NSC169105

NSC173182

Oprea1_088821

Oxytyramine

Pyrocatechol, 4-(2-aminoethyl)-

Pyrocatechol, 4-(2-aminoethyl)- (8CI)

Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride

Revimine

Sabax Dopamin

SPBio_001205

SPECTRUM1505155

Spectrum2_001023

Spectrum3_000406

Spectrum4_000525

Spectrum5_000945

Spectrum_001012

ST048774

STK301601

UNII-VTD58H1Z2X

UPCMLD0ENAT5885989:001

USAN

USP

USP)

USP); Dopamine (BAN

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -0.05 -1.62 -50.24 5 3 1 68 154.189 2

Vendor Notes

Note Type Comments Provided By
MP 218 - 220 Enamine Building Blocks
MP 218...220 Enamine Building Blocks
Mp [°C] 241 - 243 Acros Organics
Melting_Point 243-250? Alfa-Aesar
Melting_Point 243-250° Alfa-Aesar
UniProt Database Links 5H1AA_TAKRU; 5H1AB_TAKRU; 5HT1A_CANFA; 5HT1A_GORGO; 5HT1A_HORSE; 5HT1A_HUMAN; 5HT1A_MOUSE; 5HT1A_PANTR; 5HT1A_PONPY; 5HT1A_RAT; 5HT1A_VULVU; 5HT1A_XENLA; 5HT1B_CANFA; 5HT1B_CAVPO; 5HT1B_CRIGR; 5HT1B_DIDVI; 5HT1B_FELCA; 5HT1B_GORGO; 5HT1B_HORSE; 5HT1B_HUMA ChEBI
ALOGPS_SOLUBILITY 7.43e+00 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 95% Fluorochem
Purity 98% Fluorochem
therap cardiotonic, antihypotensive MicroSource Spectrum
Purity CP98 APIChem
Target Dopamine Receptor Selleck Chemicals
Therapy Endogenous neurotransmitter SMDC MicroSource
Patent Database Links EP0771800; EP0771801; EP0900568; EP0924205; EP0940401; EP0953567; EP0974363; EP1051980; EP1065205; EP1070715; EP1082289; EP1088550; EP1099438; EP1108430; EP1136071; EP1177792; EP1207159; EP1251128; EP1254661; EP1256343; EP1256578; EP1325917; EP1364957; EP ChEBI
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : H-5381; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER; 1 hydrogen chloride NIH Clinical Collection via PubChem
Indications neurotransmitter KeyOrganics Bioactives
Reactome Database Links REACT_15372; REACT_15382; REACT_15468; REACT_15485; REACT_15517; REACT_15524; REACT_15531; REACT_15533; REACT_15538; REACT_16959; REACT_17008; REACT_17033; REACT_20519; REACT_22188; REACT_22221; REACT_22234; REACT_22239; REACT_22268; REACT_22283; REACT_22 ChEBI
S phrase S24/25: Avoid contact with skin and eyes. Acros Organics
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: H-5381; SALT: 1 hydrogen chloride; SUPPLIER_COMMENTS: WHITE POWDER NIH Clinical Collection via PubChem
PUBCHEM_PATENT_ID WO1996018395A1; WO1998031362A1; WO2000006162A1; WO2000066537A1; WO2000077238A1 IBM Patent Data
MP ~240° Fluorochem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
ADA1B-1-E Alpha-1b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 61 0.92 Binding ≤ 10μM
ADA2A-3-E Alpha-2a Adrenergic Receptor (cluster #3 Of 4), Eukaryotic Eukaryotes 61 0.92 Binding ≤ 10μM
ADA2B-4-E Alpha-2b Adrenergic Receptor (cluster #4 Of 4), Eukaryotic Eukaryotes 61 0.92 Binding ≤ 10μM
ADA2C-3-E Alpha-2c Adrenergic Receptor (cluster #3 Of 4), Eukaryotic Eukaryotes 61 0.92 Binding ≤ 10μM
ADCY2-2-E Adenylate Cyclase Type II (cluster #2 Of 2), Eukaryotic Eukaryotes 5000 0.67 Binding ≤ 10μM
ADCY3-2-E Adenylate Cyclase Type III (cluster #2 Of 2), Eukaryotic Eukaryotes 5000 0.67 Binding ≤ 10μM
ADCY4-2-E Adenylate Cyclase Type IV (cluster #2 Of 2), Eukaryotic Eukaryotes 5000 0.67 Binding ≤ 10μM
ADCY5-2-E Adenylate Cyclase Type V (cluster #2 Of 2), Eukaryotic Eukaryotes 5000 0.67 Binding ≤ 10μM
ADCY6-2-E Adenylate Cyclase Type VI (cluster #2 Of 2), Eukaryotic Eukaryotes 5000 0.67 Binding ≤ 10μM
ADCY8-1-E Adenylate Cyclase Type VIII (cluster #1 Of 2), Eukaryotic Eukaryotes 5000 0.67 Binding ≤ 10μM
ADRB1-2-E Beta-1 Adrenergic Receptor (cluster #2 Of 2), Eukaryotic Eukaryotes 10000 0.64 Binding ≤ 10μM
D4A3N4-1-E Brain Adenylate Cyclase 1 (cluster #1 Of 1), Eukaryotic Eukaryotes 3500 0.69 Binding ≤ 10μM
DRD1-1-E Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 7 1.04 Binding ≤ 10μM
DRD3-1-E Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic Eukaryotes 9 1.02 Binding ≤ 10μM
DRD4-2-E Dopamine D4 Receptor (cluster #2 Of 4), Eukaryotic Eukaryotes 5340 0.67 Binding ≤ 10μM
DRD5-1-E Dopamine D5 Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 5340 0.67 Binding ≤ 10μM
MTR1A-2-E Melatonin Receptor 1A (cluster #2 Of 2), Eukaryotic Eukaryotes 7100 0.66 Binding ≤ 10μM
MTR1B-2-E Melatonin Receptor 1B (cluster #2 Of 2), Eukaryotic Eukaryotes 9100 0.64 Binding ≤ 10μM
OPRD-1-E Delta Opioid Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 3045 0.70 Binding ≤ 10μM
OPRK-2-E Kappa Opioid Receptor (cluster #2 Of 6), Eukaryotic Eukaryotes 3045 0.70 Binding ≤ 10μM
OPRM-1-E Mu-type Opioid Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 3045 0.70 Binding ≤ 10μM
Q8CFM9-1-E Adenylate Cyclase Type VII (cluster #1 Of 1), Eukaryotic Eukaryotes 3500 0.69 Binding ≤ 10μM
Q9WTR4-2-E Norepinephrine Transporter (cluster #2 Of 2), Eukaryotic Eukaryotes 7 1.04 Binding ≤ 10μM
SC6A3-3-E Dopamine Transporter (cluster #3 Of 3), Eukaryotic Eukaryotes 6400 0.66 Binding ≤ 10μM
SGMR1-4-E Sigma Opioid Receptor (cluster #4 Of 6), Eukaryotic Eukaryotes 3045 0.70 Binding ≤ 10μM
ARP19-1-E Cyclic AMP Phosphoprotein (cluster #1 Of 1), Eukaryotic Eukaryotes 3500 0.69 Functional ≤ 10μM
DRD1-1-E Dopamine D1 Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 35 0.95 Functional ≤ 10μM
DRD2-1-E Dopamine D2 Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 5 1.06 Functional ≤ 10μM
DRD4-1-E Dopamine D4 Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 2 1.11 Functional ≤ 10μM
DRD2-3-E Dopamine D2 Receptor (cluster #3 Of 24), Eukaryotic Eukaryotes 843 0.77 Binding ≤ 10μM
Z50597-1-O Rattus Norvegicus (cluster #1 Of 5), Other Other 29 0.96 Binding ≤ 10μM
Z50425-11-O Plasmodium Falciparum (cluster #11 Of 22), Other Other 10000 0.64 Functional ≤ 10μM
Z50512-1-O Cavia Porcellus (cluster #1 Of 7), Other Other 1700 0.73 Functional ≤ 10μM
Z50592-3-O Oryctolagus Cuniculus (cluster #3 Of 8), Other Other 76 0.91 Functional ≤ 10μM
Z50594-6-O Mus Musculus (cluster #6 Of 9), Other Other 10000 0.64 Functional ≤ 10μM
Z50597-12-O Rattus Norvegicus (cluster #12 Of 12), Other Other 5268 0.67 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
ADA1B_RAT P15823 Alpha-1b Adrenergic Receptor, Rat 61 0.92 Binding ≤ 1μM
ADA2A_RAT P22909 Alpha-2a Adrenergic Receptor, Rat 58 0.92 Binding ≤ 1μM
ADA2B_RAT P19328 Alpha-2b Adrenergic Receptor, Rat 58 0.92 Binding ≤ 1μM
ADA2C_RAT P22086 Alpha-2c Adrenergic Receptor, Rat 58 0.92 Binding ≤ 1μM
DRD1_RAT P18901 Dopamine D1 Receptor, Rat 150 0.87 Binding ≤ 1μM
DRD1_HUMAN P21728 Dopamine D1 Receptor, Human 100 0.89 Binding ≤ 1μM
DRD1_BOVIN Q95136 Dopamine D1 Receptor, Bovin 200 0.85 Binding ≤ 1μM
DRD2_HUMAN P14416 Dopamine D2 Receptor, Human 1.89 1.11 Binding ≤ 1μM
DRD2_BOVIN P20288 Dopamine D2 Receptor, Bovin 1.8 1.11 Binding ≤ 1μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 1.1 1.14 Binding ≤ 1μM
DRD3_HUMAN P35462 Dopamine D3 Receptor, Human 13.2 1.00 Binding ≤ 1μM
DRD3_RAT P19020 Dopamine D3 Receptor, Rat 11 1.01 Binding ≤ 1μM
DRD4_RAT P30729 Dopamine D4 Receptor, Rat 2 1.11 Binding ≤ 1μM
DRD4_HUMAN P21917 Dopamine D4 Receptor, Human 1.2 1.14 Binding ≤ 1μM
DRD5_RAT P25115 Dopamine D5 Receptor, Rat 2 1.11 Binding ≤ 1μM
DRD5_HUMAN P21918 Dopamine D5 Receptor, Human 15 1.00 Binding ≤ 1μM
SC6A3_RAT P23977 Dopamine Transporter, Rat 200 0.85 Binding ≤ 1μM
Q9WTR4_RAT Q9WTR4 Norepinephrine Transporter, Rat 6.63 1.04 Binding ≤ 1μM
Z50597 Z50597 Rattus Norvegicus 2 1.11 Binding ≤ 1μM
ADCY2_RAT P26769 Adenylate Cyclase Type II, Rat 3500 0.69 Binding ≤ 10μM
ADCY3_RAT P21932 Adenylate Cyclase Type III, Rat 3500 0.69 Binding ≤ 10μM
ADCY4_RAT P26770 Adenylate Cyclase Type IV, Rat 3500 0.69 Binding ≤ 10μM
ADCY5_RAT Q04400 Adenylate Cyclase Type V, Rat 3500 0.69 Binding ≤ 10μM
ADCY6_RAT Q03343 Adenylate Cyclase Type VI, Rat 3500 0.69 Binding ≤ 10μM
Q8CFM9_RAT Q8CFM9 Adenylate Cyclase Type VII, Rat 3500 0.69 Binding ≤ 10μM
ADCY8_RAT P40146 Adenylate Cyclase Type VIII, Rat 3500 0.69 Binding ≤ 10μM
ADA1B_RAT P15823 Alpha-1b Adrenergic Receptor, Rat 61 0.92 Binding ≤ 10μM
ADA2A_RAT P22909 Alpha-2a Adrenergic Receptor, Rat 58 0.92 Binding ≤ 10μM
ADA2B_RAT P19328 Alpha-2b Adrenergic Receptor, Rat 58 0.92 Binding ≤ 10μM
ADA2C_RAT P22086 Alpha-2c Adrenergic Receptor, Rat 58 0.92 Binding ≤ 10μM
ADRB1_RAT P18090 Beta-1 Adrenergic Receptor, Rat 10000 0.64 Binding ≤ 10μM
D4A3N4_RAT D4A3N4 Brain Adenylate Cyclase 1, Rat 3500 0.69 Binding ≤ 10μM
OPRD_RAT P33533 Delta Opioid Receptor, Rat 3045 0.70 Binding ≤ 10μM
DRD1_RAT P18901 Dopamine D1 Receptor, Rat 150 0.87 Binding ≤ 10μM
DRD1_BOVIN Q95136 Dopamine D1 Receptor, Bovin 1600 0.74 Binding ≤ 10μM
DRD1_HUMAN P21728 Dopamine D1 Receptor, Human 100 0.89 Binding ≤ 10μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 1.1 1.14 Binding ≤ 10μM
DRD2_HUMAN P14416 Dopamine D2 Receptor, Human 1.89 1.11 Binding ≤ 10μM
DRD2_BOVIN P20288 Dopamine D2 Receptor, Bovin 1.8 1.11 Binding ≤ 10μM
DRD3_RAT P19020 Dopamine D3 Receptor, Rat 11 1.01 Binding ≤ 10μM
DRD3_HUMAN P35462 Dopamine D3 Receptor, Human 13.2 1.00 Binding ≤ 10μM
DRD4_HUMAN P21917 Dopamine D4 Receptor, Human 1.2 1.14 Binding ≤ 10μM
DRD4_RAT P30729 Dopamine D4 Receptor, Rat 2 1.11 Binding ≤ 10μM
DRD5_RAT P25115 Dopamine D5 Receptor, Rat 2 1.11 Binding ≤ 10μM
DRD5_HUMAN P21918 Dopamine D5 Receptor, Human 15 1.00 Binding ≤ 10μM
SC6A3_HUMAN Q01959 Dopamine Transporter, Human 6400 0.66 Binding ≤ 10μM
SC6A3_RAT P23977 Dopamine Transporter, Rat 200 0.85 Binding ≤ 10μM
OPRK_RAT P34975 Kappa Opioid Receptor, Rat 3045 0.70 Binding ≤ 10μM
MTR1A_HUMAN P48039 Melatonin Receptor 1A, Human 7100 0.66 Binding ≤ 10μM
MTR1B_HUMAN P49286 Melatonin Receptor 1B, Human 9100 0.64 Binding ≤ 10μM
OPRM_RAT P33535 Mu Opioid Receptor, Rat 3045 0.70 Binding ≤ 10μM
Q9WTR4_RAT Q9WTR4 Norepinephrine Transporter, Rat 6.63 1.04 Binding ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 2 1.11 Binding ≤ 10μM
SGMR1_RAT Q9R0C9 Sigma Opioid Receptor, Rat 3045 0.70 Binding ≤ 10μM
Z50512 Z50512 Cavia Porcellus 1500 0.74 Functional ≤ 10μM
ARP19_RAT Q712U5 Cyclic AMP Phosphoprotein, Rat 3500 0.69 Functional ≤ 10μM
DRD1_HUMAN P21728 Dopamine D1 Receptor, Human 37 0.95 Functional ≤ 10μM
DRD1_RAT P18901 Dopamine D1 Receptor, Rat 3500 0.69 Functional ≤ 10μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 1.1 1.14 Functional ≤ 10μM
DRD2_HUMAN P14416 Dopamine D2 Receptor, Human 0.1 1.27 Functional ≤ 10μM
DRD4_RAT P30729 Dopamine D4 Receptor, Rat 2.4 1.10 Functional ≤ 10μM
DRD4_HUMAN P21917 Dopamine D4 Receptor, Human 10 1.02 Functional ≤ 10μM
Z50594 Z50594 Mus Musculus 10000 0.64 Functional ≤ 10μM
Z50592 Z50592 Oryctolagus Cuniculus 38 0.94 Functional ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 10000 0.64 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 1437 0.74 Functional ≤ 10μM

Direct Reactome Annotations (via ChEBI)

Description Species
Catecholamine biosynthesis
Cytosolic sulfonation of small molecules
Dopamine clearance from the synaptic cleft
Dopamine Neurotransmitter Release Cycle
Dopamine receptors
Enzymatic degradation of dopamine by COMT
Enzymatic degradation of Dopamine by monoamine oxidase
G alpha (i) signalling events
G alpha (s) signalling events
Na+/Cl- dependent neurotransmitter transporters
Norepinephrine Neurotransmitter Release Cycle
Organic cation transport
Transport of nucleosides and free purine and pyrimidine bases across the plasma

Reactome Annotations from Targets (via Uniprot)

Description Species
Adenylate cyclase activating pathway
Adenylate cyclase inhibitory pathway
Adrenaline signalling through Alpha-2 adrenergic receptor
Adrenaline,noradrenaline inhibits insulin secretion
Adrenoceptors
Class A/1 (Rhodopsin-like receptors)
CREB phosphorylation through the activation of Adenylate Cyclase
Dopamine clearance from the synaptic cleft
Dopamine receptors
G alpha (i) signalling events
G alpha (s) signalling events
G alpha (z) signalling events
G-protein activation
Glucagon signaling in metabolic regulation
MASTL Facilitates Mitotic Progression
Na+/Cl- dependent neurotransmitter transporters
Opioid Signalling
Peptide ligand-binding receptors
PKA activation
PKA activation in glucagon signalling
Vasopressin regulates renal water homeostasis via Aquaporins

Analogs ( Draw Identity 99% 90% 80% 70% )